| 50419-342 | Ultravist | iopromide | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-342 | Ultravist | iopromide | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-342 | Ultravist | iopromide | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-342 | Ultravist | iopromide | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-344 | Ultravist | iopromide | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-344 | Ultravist | iopromide | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-344 | Ultravist | iopromide | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-344 | Ultravist | iopromide | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-344 | Ultravist | iopromide | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-344 | Ultravist | iopromide | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-344 | Ultravist | iopromide | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-344 | Ultravist | iopromide | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-346 | Ultravist | iopromide | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-346 | Ultravist | iopromide | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-346 | Ultravist | iopromide | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-346 | Ultravist | iopromide | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-346 | Ultravist | iopromide | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-346 | Ultravist | iopromide | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-346 | Ultravist | iopromide | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-346 | Ultravist | iopromide | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |